[HTML][HTML] Fc-mediated antibody effector functions during respiratory syncytial virus infection and disease
EA Van Erp, W Luytjes, G Ferwerda… - Frontiers in …, 2019 - frontiersin.org
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections
and hospitalization in infants under 1 year of age and there is currently no market-approved …
and hospitalization in infants under 1 year of age and there is currently no market-approved …
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
EA van Erp, W Luytjes, G Ferwerda… - Frontiers in …, 2019 - hero.epa.gov
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections
and hospitalization in infants under 1 year of age and there is currently no market-approved …
and hospitalization in infants under 1 year of age and there is currently no market-approved …
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.
EA van Erp, W Luytjes, G Ferwerda… - Frontiers in …, 2019 - europepmc.org
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections
and hospitalization in infants under 1 year of age and there is currently no market-approved …
and hospitalization in infants under 1 year of age and there is currently no market-approved …
[引用][C] Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.
EA van Erp, W Luytjes, G Ferwerda, PB van Kasteren - 2019 - rivm.openrepository.com
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections
and hospitalization in infants under 1 year of age and there is currently no market-approved …
and hospitalization in infants under 1 year of age and there is currently no market-approved …
[PDF][PDF] Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
EA van Erp, W Luytjes, G Ferwerda, PB van Kasteren - 2019 - repository.ubn.ru.nl
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections
and hospitalization in infants under 1 year of age and there is currently no market-approved …
and hospitalization in infants under 1 year of age and there is currently no market-approved …
[引用][C] Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
EA van Erp, W Luytjes, G Ferwerda… - Frontiers in …, 2019 - cir.nii.ac.jp
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and
Disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
EA van Erp, W Luytjes, G Ferwerda… - Fc-Mediated Antibody …, 2020 - books.google.com
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections
and hospitalization in infants under 1 year of age and there is currently no market-approved …
and hospitalization in infants under 1 year of age and there is currently no market-approved …
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
EA van Erp, W Luytjes, G Ferwerda… - Frontiers in …, 2019 - pubmed.ncbi.nlm.nih.gov
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections
and hospitalization in infants under 1 year of age and there is currently no market-approved …
and hospitalization in infants under 1 year of age and there is currently no market-approved …
[HTML][HTML] Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
EA van Erp, W Luytjes, G Ferwerda… - Frontiers in …, 2019 - ncbi.nlm.nih.gov
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections
and hospitalization in infants under 1 year of age and there is currently no market-approved …
and hospitalization in infants under 1 year of age and there is currently no market-approved …
[PDF][PDF] Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
EA van Erp, W Luytjes, G Ferwerda… - Front. Immunol. 10: 548 …, 2019 - core.ac.uk
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections
and hospitalization in infants under 1 year of age and there is currently no market-approved …
and hospitalization in infants under 1 year of age and there is currently no market-approved …